The primary observed alterations in non-small cell lung cancer (NSCLC) related to HER2 consist of mutations, amplifications, and overexpression, with exon 20 insertion mutations being the most prevalent29. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.